Browse by Poster Title

92 results found

Type here to filter the list

Sort by #

Sort by Title

A
JL1001C
A Bone Marrow Aspirate and Biopsy Educational Program for Advanced Practice Providers Utilizing Task Trainers
Clinical Posters

Favorite
JL1001E
Adoption and early clinical outcomes of atezolizumab (atezo) + carboplatin and etoposide (CE) in patients with extensive-stage small cell lung cancer (ES-SCLC) in the real-world (RW) setting
Industry Encore Posters

Favorite
JL1002C
Advanced Practice Provider–Led Initiative to Improve Germline Testing for Pancreatic Cancer in a Multilocation Practice
Clinical Posters

Favorite
JL1004C
Advanced Practitioner Leadership, Achievements in Increasing Satisfaction and Reducing Burnout
Clinical Posters

Favorite
JL1003C
An Advanced Practice Provider–Run Lymphadenopathy Clinic: The Cleveland Clinic Experience
Clinical Posters

Favorite
JL1001P
Assessing Patient Engagement in Clinical Trials Decision-Making for Advanced Prostate Cancer
APSHO Patient Perspective Posters

Favorite
JL1002E
Association between patient-reported outcomes (PROs) and changes in prostate-specific antigen (PSA) in patients (pts) with advanced prostate cancer treated with apalutamide (APA) in SPARTAN and TITAN studies
Industry Encore Posters

Favorite
JL1003E
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): long-term follow-up results from the JAVELIN Bladder 100 trial
Industry Encore Posters

Favorite
B
JL1002P
Barriers in the Path of Maintaining Well-being for Colorectal Cancer Patients and Caregivers
APSHO Patient Perspective Posters

Favorite
JL1005C
Building Best Practice for Oral Antineoplastic Therapy Programs: A Model for Multisite, Advanced Practitioner–Led, Quality Care Initiatives
Clinical Posters

Favorite
JL1003P
Building Block of Hope®: A Model for Advanced Practitioner Global Advocacy
APSHO Patient Perspective Posters

Favorite
JL1006C
Burkitt’s Lymphoma During Pregnancy: A Case Report and Review
Clinical Posters

Favorite
C
JL1007C
Care Coordination Strategies for Patients Receiving Combination IV and Oral Anticancer Therapy: Findings for Advanced Practitioners From a National Mixed-Methods Study
Clinical Posters

Favorite
JL1004E
Clinical Outcomes of Patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) with Prostate-Specific Antigen (PSA) Decline to Undetectable Levels on Enzalutamide (ENZA): Post Hoc Analysis of ARCHES
Industry Encore Posters

Favorite
JL1005E
Clinical Strategies for Mitigation of Cytokine Release Syndrome and Neurotoxicity With Chimeric Antigen Receptor T Cell Therapy Ciltacabtagene Autoleucel in Multiple Myeloma
Industry Encore Posters

Favorite
JL1004P
COLONTOWN University Increases Engagement for Colorectal Patients and Health-Care Providers
APSHO Patient Perspective Posters

Favorite
JL1005P
Complex Biomarker Reports Suggest Need for Patient-Friendly Reporting and Education
APSHO Patient Perspective Posters

Favorite
JL1006E
Cost-effectiveness of atezolizumab for adjuvant treatment of patients with stage II-IIIA PD-L1+ non-small cell lung cancer
Industry Encore Posters

Favorite
D
JL1008C
Development of an Inpatient Admission Infusion Center to Improve Admission Flow and Patient Experience
Clinical Posters

Favorite
JL1009C
Development of an Oncology Acute Care Clinic Dashboard to Assess Patient Outcomes
Clinical Posters

Favorite
JL1010C
Development of an Overnight Virtual Advanced Practice Provider to Support Night Shift On-Site Staffing
Clinical Posters

Favorite
JL1007E
Disease-free survival with longer follow-up from the phase 3 CheckMate 274 trial of adjuvant nivolumab in patients who underwent surgery for high-risk muscle-invasive urothelial carcinoma
Industry Encore Posters

Favorite
JL1008E
Dostarlimab in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability–high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): the GARNET study
Industry Encore Posters

Favorite
E
JL1011C
Early Identification for Fertility Preservation Improves Referrals in a Community Oncology Practice
Clinical Posters

Favorite
JL1006P
Effective Collaboration on a Guide for People With Neuroendocrine Cancer
APSHO Patient Perspective Posters

Favorite
JL1009E
Efficacy and safety of talquetamab, a G protein-coupled receptor family C group 5 member D x CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM): updated results from MonumenTAL-1
Industry Encore Posters

Favorite
JL1010E
Efficacy and safety of teclistamab (tec), a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM) after exposure to other BCMA-targeted agents
Industry Encore Posters

Favorite
JL1012C
Empowering Patients With the Advanced Practitioner as a Vital Member of a Novel, Independent, Oncology Advisory Service
Clinical Posters

Favorite
JL1007P
Engaging Caregivers in Supporting Both Loved Ones and Oncology Providers
APSHO Patient Perspective Posters

Favorite
JL1011E
EPIK-B4: a phase 2, randomized study of metformin (MET) extended release (XR) +/− dapagliflozin (DAPA) to prevent hyperglycemia (HG) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–), PIK3CA-mutated (mut) advanced breast cancer (ABC) treated with alpelisib (ALP) and fulvestrant (FUL)
Industry Encore Posters

Favorite
JL1012E
Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States
Industry Encore Posters

Favorite
JL1013C
Examining the Role of Psychological Safety and Its Relationship With Clinician Well-Being Among Advanced Practitioners
Clinical Posters

Favorite
JL1008P
Experts by Experience: Paving a Pathway to Engage Underrepresented Oncology Patients in the Research Ecosystem
APSHO Patient Perspective Posters

Favorite
F
JL1013E
First Prospective Data on Minimal Residual Disease (MRD) Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax (Ibr+Ven) Versus Chlorambucil Plus Obinutuzumab (Clb+O) for First-Line Treatment of CLL in Elderly or Unfit Patients: The GLOW Study
Industry Encore Posters

Favorite
JL1014E
First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) + R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL): phase 1/2 data update
Industry Encore Posters

Favorite
G
JL1015E
Gene by gene analysis in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
Industry Encore Posters

Favorite
H
JL1016E
Health-related quality of life (HRQoL) and pain in the MAGNITUDE study of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair (HRR) gene alterations
Industry Encore Posters

Favorite
JL1014C
Hematology Oncology Fellowships: A New Frontier for Advanced Practice Providers
Clinical Posters

Favorite
I
JL1017E
Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide in Men with Advanced Prostate Cancer: Subgroup Analysis from the Phase 3 HERO Study
Industry Encore Posters

Favorite
JL1009P
Impact of the Cholangiocarcinoma Foundation’s Newly Diagnosed Program
APSHO Patient Perspective Posters

Favorite
JL1015C
Implementation of an Advanced Practice Provider Career Pathway at a Major Metropolitan NCI-Designated Comprehensive Cancer Center
Clinical Posters

Favorite
JL1016C
Implementing Antineoplastic Prescribing for Advanced Practitioners (APs)
Clinical Posters

Favorite
JL1017C
Importance of Germline Testing in Colorectal Cancer Patients
Clinical Posters

Favorite
JL1018C
Incidence of Venous Thromboembolism and Patterns of Anticoagulation in Patients with Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia: A Population-Based Study
Clinical Posters

Favorite
JL1010P
Increasing Health-Care Professionals' Awareness of Critical Cancer Legal Issues
APSHO Patient Perspective Posters

Favorite
JL1019C
Infusion Center Pilot Program for Patients with Multiple Myeloma
Clinical Posters

Favorite
JL1018E
Initial safety results for MagnetisMM-3: A phase 2 trial of elranatamab, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients (pts) with relapsed/refractory (R/R) multiple myeloma (MM)
Industry Encore Posters

Favorite
JL1020C
Intermittent Fasting During Systemic Therapy: Evidence for the Oncology Advanced Practitioner
Clinical Posters

Favorite
JL1021C
Interprofessional Analysis and Revision of an Oral Antineoplastic Medication Adherence Toolkit
Clinical Posters

Favorite
L
JL1022C
Lesbian-, Gay-, Bisexual-, Transgender-, Questioning- or Queer-, Intersex-, and Asexual-Inclusive Health Care Versus Traditional: Comparing Patient Satisfaction
Clinical Posters

Favorite
JL1023C
Leveraging Technology to Develop a Series of Education Programs for Advanced Practice Providers at a Large Community Oncology Network
Clinical Posters

Favorite
JL1019E
Long-term PFS from TIVO-3: Tivozanib (TIVO) vs sorafenib (SOR) in relapsed/refractory (R/R) advanced RCC
Industry Encore Posters

Favorite
M
JL1024C
Malignant Hematology Procedures Workshop: An Educational Pilot Project Utilizing Simulators
Clinical Posters

Favorite
JL1011P
Multiple Myeloma Research Foundation CureCloud Study: Patients and Researchers Collaborating Towards Cures
APSHO Patient Perspective Posters

Favorite
N
JL1020E
Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma: expanded analyses from 24-month follow-up of CheckMate 649
Industry Encore Posters

Favorite
JL1012P
Nurse Navigation to Overcome Barriers to Blood Cancer Clinical Trial Participation
APSHO Patient Perspective Posters

Favorite
JL1013P
Nutrition and Physical Activity Post Cholangiocarcinoma Diagnosis
APSHO Patient Perspective Posters

Favorite
O
JL1025C
Optimizing Outcomes for Patients With Pancreatic Cancer
Clinical Posters

Favorite
JL1021E
Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer: Detailed Safety Analysis from the Randomized Phase 3 HERO Study
Industry Encore Posters

Favorite
JL1022E
Overall survival with first-line palbociclib plus an aromatase inhibitor (AI) vs AI in metastatic breast cancer: A large real-world database analysis
Industry Encore Posters

Favorite
P
JL1023E
Patient (pt) population and radiation therapy (RT) type in the long-term phase 3 double-blind, placebo (PBO)-controlled ATLAS study of apalutamide (APA) added to androgen deprivation therapy (ADT) in high-risk localized or locally advanced prostate cancer (HRLPC)
Industry Encore Posters

Favorite
JL1024E
Patient Identification for Chimeric Antigen Receptor T-Cell Therapy: Initial Insights From the CARTITUDE Program in Multiple Myeloma
Industry Encore Posters

Favorite
JL1025E
Phase 3 multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder
Industry Encore Posters

Favorite
JL1026C
Pivoting During a Pandemic: Creation of an Oncology Procedure Team
Clinical Posters

Favorite
JL1027E
Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer.
Industry Encore Posters

Favorite
JL1028E
PRIMARY RESULTS OF SUBCUTANEOUS EPCORITAMAB DOSE EXPANSION IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A PHASE 2 STUDY
Industry Encore Posters

Favorite
JL1027C
Promoting Self-Care to Reduce Compassion Fatigue in Oncology Nurses and Advanced Practice Providers: An Evidence-Based Practice Implementation Project
Clinical Posters

Favorite
R
JL1029E
Reasons for Oncologist and Urologist Treatment Choice in Metastatic Castration-Sensitive Prostate Cancer (mCSPC): A Physician Survey Linked to Patient Chart Reviews in the United States
Industry Encore Posters

Favorite
JL1030E
Relatlimab and nivolumab versus nivolumab in previously untreated metastatic or unresectable melanoma: Overall survival and response rates from RELATIVITY-047 (CA224-047)
Industry Encore Posters

Favorite
JL1031E
Risk and Management of Intracranial Progression on Amivantamab in Epidermal Growth Factor Receptor (EGFR) Exon 20 insertion (ex20ins)-mutated Non-small Cell Lung Cancer (NSCLC)
Industry Encore Posters

Favorite
JL1028C
Role of the Advanced Practice Provider in a Multidisciplinary Colorectal Tumor Board
Clinical Posters

Favorite
S
JL1032E
Stable disease (SD) on amivantamab in post-platinum epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutated non-small cell lung cancer (NSCLC): A response-based analysis
Industry Encore Posters

Favorite
JL1029C
Strategies for Optimization and Growth of an Oncology Symptom Management Advanced Practice Provider–Driven Clinic
Clinical Posters

Favorite
JL1033E
Subcutaneous epcoritamab with rituximab + lenalidomide (R2) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): update from phase 1/2 trial
Industry Encore Posters

Favorite
JL1034E
SunRISe-1: phase 2b study of TAR-200 in combination with cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to intravesical bacillus Calmette-Guérin who are ineligible for or elected not to undergo radical cystectomy
Industry Encore Posters

Favorite
T
JL1030C
The Development of a Biomarker Database: Creating a Clinical Decision Support Tool for Oncology Nurses and Advanced Practice Providers
Clinical Posters

Favorite
JL1031C
The Development of an Advanced Practice Hematology, Oncology, and Palliative Medicine Fellowship: Improving Onboarding and Retention
Clinical Posters

Favorite
JL1035E
The Economic Impact of Treatment Sequences for Chronic Lymphocytic Leukemia (CLL) in the United States: A Cost of Care and Budget Impact Model of Venetoclax plus Obinutuzumab Sequences for CLL Patients
Industry Encore Posters

Favorite
JL1014P
The Effectiveness of a Peer Specialist Training Program
APSHO Patient Perspective Posters

Favorite
JL1036E
The Efficacy of Enzalutamide (ENZA) Plus Androgen Deprivation Therapy (ADT) on Oligometastatic Hormone-Sensitive Prostate Cancer: Extended Post Hoc Analysis of ARCHES
Industry Encore Posters

Favorite
JL1032C
The Expanding Role of the Advanced Practice Provider in National Cancer Institute–Sponsored Trials
Clinical Posters

Favorite
JL1015P
The Psychosocial Factors Impacting African American Women Breast Cancer Survivors
APSHO Patient Perspective Posters

Favorite
JL1033C
The Surgical Oncology Advanced Practitioner Conference (2018–2021): Evaluating Educational Gaps, Needs Assessment, and Future Programs
Clinical Posters

Favorite
JL1037E
Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial
Industry Encore Posters

Favorite
JL1038E
Treatment Duration and Long-term Outcomes With Daratumumab in Transplant-ineligible Newly Diagnosed Multiple Myeloma From the Phase 3 MAIA Study
Industry Encore Posters

Favorite
JL1039E
Tumor agnostic efficacy and safety of erdafitinib in patients with advanced solid tumors with prespecified fibroblast growth factor receptor alterations (FGFRalt) in RAGNAR: interim analysis results
Industry Encore Posters

Favorite
U
JL1034C
Understanding the Role of Oncology Advanced Practice Providers in Prescribing Anticancer Therapies and Related Privileging Practices
Clinical Posters

Favorite
JL1034C
Understanding the Role of Oncology Advanced Practice Providers in Prescribing Anticancer Therapies and Related Privileging Practices
Clinical Posters

Favorite
JL1040E
Unfiltered Patient Insights: Commonalities and Differences in Living With Chronic Myeloid Leukemia and Multiple Myeloma
Industry Encore Posters

Favorite
JL1041E
Updated efficacy and safety from the phase 3 CROWN study of first-line lorlatinib vs crizotinib in advanced anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)
Industry Encore Posters

Favorite
JL1035C
Utilization of Circulating Tumor DNA as a Biomarker in Patients With Resectable Colorectal Liver Metastasis: A Case Report on Oncologic Surveillance and Detection of Disease Recurrence
Clinical Posters

Favorite
W
JL1036C
Work Unit-Level Drivers of Burnout Among Advanced Practitioners in Outpatient Hematology Practice at an Academic Medical Center
Clinical Posters

Favorite